|
HS Code |
482717 |
| Chemical Name | 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid |
| Cas Number | 14338-32-6 |
| Molecular Formula | C10H13NO3 |
| Molecular Weight | 195.22 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 114-117°C |
| Solubility | Soluble in water and polar organic solvents |
| Purity | Typically ≥98% |
| Storage Conditions | Store at 2-8°C, protect from light and moisture |
As an accredited 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a sealed amber glass bottle containing 25 grams, with a printed hazard label and tamper-evident cap for safety. |
| Shipping | 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid is shipped in compliance with chemical safety regulations. The product is securely packed in airtight, moisture-resistant containers to prevent contamination and degradation. Appropriate hazard labeling and documentation are provided, and the package is shipped via certified carriers to ensure safe and timely delivery. |
| Storage | 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid should be stored in a tightly sealed container, protected from light, moisture, and air. Keep it at room temperature (15–25°C) in a dry, well-ventilated area, away from incompatible substances such as strong oxidizers. Always label the container properly and follow laboratory safety protocols to prevent degradation or contamination. |
Applications of 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid in Industrial Manufacturing3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid is a specialized intermediate used in the synthesis of selected pharmaceuticals, specialty agrochemicals, and advanced chemical building blocks. As the original manufacturer, we support leading industry players with reliable supply tailored to the exacting requirements of each downstream sector. Below we detail the primary industrial applications, covering compliance, formulation, process, and finished goods integration. 1. Non-Steroidal Anti-Inflammatory Drug (NSAID) SynthesisIn the pharmaceutical industry, this material is a protected intermediate for synthesizing analogues of well-characterized NSAIDs featuring methoxyphenyl and aminopropionic acid fragments. Formulators integrate this raw material during early-stage active pharmaceutical ingredient (API) construction, where it contributes to the specific substitution patterns required for target molecule structure and activity. Batch and continuous process lines adjust input volumes according to API design and regulatory process validation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Advanced Agrochemical Intermediate ManufacturingChemical producers in the agro sector use this compound as a building block for creating new-generation herbicide and fungicide actives. Its amino and methoxyphenyl groups provide molecular flexibility to design targeting agents with increased selectivity and reduced environmental persistence. The raw material’s addition is calibrated for each crop protection chemistry according to downstream coupling partner and yield targets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chiral Building Block for Peptidomimetic API DevelopmentSpecialty pharmaceutical and biotech manufacturers use the compound as a non-proteinogenic amino acid in peptidomimetic drug design. The unique substitution enables specific spatial configurations necessary for target enzyme inhibition and receptor binding. Highly regulated peptide production facilities integrate this intermediate into solid-phase or solution-phase synthesis protocols, demanding controlled input to guarantee product reproducibility and regulatory traceability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. R&D Chemical Toolkit Supply for Pharmaceutical DiscoveryContract research organizations (CROs) and pharmaceutical R&D labs purchase this compound to accelerate lead optimization and structure-activity relationship studies. Its precise reactivity profile supports the introduction of custom side chains into drug candidates, with inventory protocols and handling designed for small batch synthesis across high-throughput parallel processes. Laboratories dose the raw material based on projected library scope and desired chemical diversity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Active Component Precursor in Diagnostic Chemical Reagent SynthesisManufacturers of clinical and research diagnostic kits integrate this intermediate during synthesis of specialty reagents designed for enzymatic assays and receptor-binding screens. The structure provides critical interaction points for conjugation or labeling, allowing downstream production of detection systems with enhanced selectivity. The compound is added according to the design of each detection chemistry, with quality control checks tied to downstream analytically validated endpoints. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
On the production lines here, 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid stands out among specialty amino acids. Many labs come to us searching for this precise compound, and the teams working in synthesis and purification rely on industry-hardened methods. This isn’t a theoretical project assembled in a quiet environment; we scale from batch development to hundreds of kilograms while keeping batch variability in check, meeting project needs for pharmaceutical and chemical development.
Our process routes carve out a cleaner product profile, deliberately sidestepping the pitfalls of impurity carryover. Each time we prepare the acid form—sometimes called 3-(3-methoxyphenyl)-β-alanine—process quality targets completeness of reaction and ease of downstream purification. Years of refining the oxidation and amidation stages have trimmed unnecessary complexity, which lets us keep tight specifications for melting point, LC purity, and color—all key for downstream success with peptide coupling or other organic transformations.
Chemists on the synthesis benches need to trust the identity and consistency of their starting material. We carry out lot-by-lot authentication using HPLC, NMR, and IR, comparing spectral fingers to historical controls. We’ve learned the cost of skipping these checks—strange byproducts in peptide synthesis or misfires in key carbon-carbon coupling reactions. When research partners reach out for details, we share full certificate of analysis data and offer reference spectra from our own archives.
For groups working on peptides, small-molecule actives, and custom intermediates, the methoxy group at the meta position gives a subtle twist on reactivity compared to other aryl-β-alanine analogues. It opens the door for conjugations that demand electron-rich aromatic rings, while the amino handle on the beta carbon gives direct access to amide or carbamate derivatives. Users have described the difference in coupling yields and solubility in DMF and similar solvents—every structural tweak impacts real-world process metrics.
In actual production runs, our 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid (model: AMPA-3M) meets purity benchmarks of >99% by HPLC, with controlled water content <0.5%. Color ranges from off-white to pale yellow, as subtle differences in ring substitution bring out slight differences during crystallization. Melting point consistency hovers reliably, a signal that we’re not getting polymorphic shifts or unplanned co-crystallization with process solvents.
Most scientists sourcing this product care about reactivity, crystallinity, and robust supply. We do not shortcut on titration or chiral purity—the synthetic method yields a racemate, and for customers demanding enantiopure samples, we can extend to customized resolution steps. Grain size controls are adjusted based on feedback from processor teams, especially when plugs or caking show up during transfers. We have learned that flowable, non-hygroscopic powder supports easy weighing in glove boxes, where even a minor clump can slow down a multi-step synthesis.
Pharmaceutical innovators often pick 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid for preclinical scaffold synthesis, looking to build off the aminopropionic acid backbone. In these settings, time pressure and data quality matter more than bulk price. Over the years, the product has found its way into small libraries of CNS candidates, peptidomimetic design, and even drug linker structures, all because the methoxy group and amino acid framework unlock routes not available with plain phenylalanine or tyrosine.
Custom polymer projects have used the meta-methoxy variant for exploring new co-monomers with electron-rich aromatic properties or targeted hydrogen bonding. In academia, we’ve supported grant-funded projects attempting asymmetric derivatization, appreciating that graduate students need reliable, clean materials for publishing reproducible data.
On the industrial side, once a customer moves from milligram to kilogram scale, process support shifts focus. Stability during long-term storage becomes crucial, as does packaging that keeps moisture away and protects from photolytic discoloration. We invested in HDPE drum lining and vacuum sealing because small changes in handling can ripple into sticky powders or darkened product—not just cosmetic, but changing how downstream chemistry behaves.
Our teams keep track of customer feedback comparing this methoxy-phenyl derivative to more standard 3-phenylpropionic acid and para-substituted analogs. The meta substitution changes electron distribution around the ring, influencing how the compound undergoes nitration, halogenation, and even mild oxidation by design, a subtlety someone working off textbook data often misses.
Reacting the methoxy-variant using standard peptide coupling yields higher initial purity in EDC/HOBt protocols and less epimerization under standard conditions. The pKa shift creates a different response in derivatization or salt formation, which might reduce side product formation when working with delicate protecting groups. Solubility reports from the field show this product dissolves more rapidly in acetonitrile and DMF when compared to unsubstituted analogs, making process chromatography less cumbersome.
From a crystallography angle, the meta-methoxy group changes packing, occasionally producing needles instead of plates. This matters for reactor filtration and sometimes for analytical sample preparation, giving a true side-by-side difference from para or ortho analogues. For chemists tuning reactivity or crystallization processes, picking between these closely related acids often depends on nuanced, hard-won laboratory observations, not just textbook charts.
We regularly collect and apply feedback—both positive and negative—from industrial partners. A few years back, a major issue appeared with minor oxide impurities from batch-to-batch, traced to subtle changes in the oxidative step temperature. Adjustments to the thermal regime, as well as replacement of batch-distilled solvents with freshly purified grades, cleared up consistency. Open conversations with synthetic teams showed that even small tweaks on our end let downstream users avoid unnecessary repeat runs or side reaction troubleshooting. Real-world chemistry rarely sticks to single paths, so learning from each production run brings lasting improvements.
Frequent feedback from peptide chemists and material scientists helped us fine-tune grain size by adjusting crystallization seeding, favoring powders that pour easily and dissolve smoothly. We have leaned on analytical lab teams to check each production run with a fresh battery of tests, ensuring any anomalies get flagged well before delivery. Instead of generic release criteria, we dig deeper when unusual byproducts pop up or when customers hint at subtle problems, because recurring issues show up fastest on the process floor, not in a distant sales report.
Quality systems here push well beyond a checklist. We integrate instrument calibration, run split-sample verifications, and set aside library samples from every lot. Repeat customers become partners in troubleshooting small issues and driving innovation. During scale-up, engineers and chemists operate side by side, testing new process parameters only after careful bench-scale exploration confirms safety and reliability. Our familiarity with this compound’s quirks—such as minor yellowing from too much reactor oxygen or stubborn traces of solvent—comes from seeing the full life cycle across hundreds of batches.
Upstream controls in raw material sourcing set up every batch with clean building blocks. Strict in-process sample pulls and rapid-response analytical checks help create a final product that consistently meets published specs. This direct engagement on the production floor minimizes the fix-later mindset that many traders and third-party blenders get trapped in. Experience shapes the quality measures we live by, not just pursuit of compliance for a certification wall.
Handling sensitive, high-value building blocks like 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid exposes us to recurring issues—delicate inventory management, regulatory changes, and sudden surges in demand. These aren’t abstract business risks, but daily realities from the manufacturing floor. Buffers in production scheduling, extra purified solvents on standby, and quick adjustments to staffing have helped us keep up with swings in the research and pharma landscape.
Shipping presents unique headaches. Packaging must survive insulation challenges in winter, while in summer, heat and humidity might alter product appearance or reactivity. Facilities keep climate-controlled storage and rapid-access QA labs to intercept any lots showing out-of-trend features. Rarely does a season go by without needing to overhaul one piece of the supply chain, all to keep downstream process teams from facing preventable setbacks.
Years of making, not just selling, 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid have taught us which details drive better research and production outcomes. Tightly maintained reaction conditions, paired with up-to-date analytical tools, keep product specs sharp. Open lines of communication with seasoned scientists in the field pave the way for process tweaks—sometimes a change as subtle as a tweak in solvent drying, sometimes an overhaul of the crystallization setup. Direct manufacturing experience replaces theory with results visible in every delivered drum.
Teams at research hubs and contract facilities count on fast, accurate responses to questions about composition and handling. They do not have patience for sales scripts or hand-waving over real performance gaps. Our staff responds to detailed questions about batch data, process improvements, and scale-up pitfalls, drawing directly from previous production records and experimental tweaks.
Chemistry-driven manufacturing relies on long-term partnerships—not just single transactions. Repeat business grows from reliable supply, in-depth technical support, and the ability to resolve any process hiccup quickly. We stand ready to offer not just product, but the experience earned through years of seeing what works and what leads to extra purification, failed reactions, or delivery delays.
Many of our clients use this compound as a springboard into new chemical space, creating modified peptides, advanced intermediates, or materials with fine-tuned physical properties. They count on consistent quality, clear documentation, and thoughtful support. If a process goes sideways or a specification tightening becomes necessary, we apply hard-earned production knowledge—sometimes proposing alternate purification or analysis steps, sometimes ramping up capacity to avoid bottlenecks.
Peer-to-peer conversations between our chemists and partners solve challenges before they grow. Whether it’s troubleshooting a stuck filtration or fine-tuning solubility ahead of preparative HPLC, drawing on real production experience plays a decisive role.
Every batch of 3-Amino-3-(3-Methoxy-Phenyl)-Propionic Acid provides a chance to refine process control and incorporate feedback. Collaboration with users across research, development, and production influences small improvements—more consistent texture, faster dissolution, or reduced side products. The learning loop runs both ways; researchers uptrend new synthetic requests while our teams offer real-world advice on manufacturability.
With continuous investment in process stability, up-to-date analytics, and responsive technical support, we aim to keep this key intermediate both accessible and reliable, supporting the growth of innovative chemistry across the world. The compound’s real value rises out of manufacturing insight and decades of close partnership between bench and plant, built batch after batch into each delivered package.